Clinical trial
SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled…
NCT01475721 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT01475721 |
|---|---|
| Title | SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma. |
| Official title | SAS115359, a Safety and Efficacy Study of Inhaled Fluticasone Propionate/Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of Adolescent and Adult Subjects With Asthma |
| Acronym | AUSTRI |
| Lead sponsor | GlaxoSmithKline, Industry |
| Collaborators | Parexel Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | ADVAIR 100/50mcg, ADVAIR 250/50mcg, ADVAIR 500/50mcg, FLOVENT 100mcg, FLOVENT 250mcg, FLOVENT 500mcg |
| Enrollment | 11,751 |
| Start date | Nov 18, 2011 |
| Primary completion | Jun 23, 2015 |
| Completion | Jun 23, 2015 |
| First posted | Nov 21, 2011 |
| Last update posted | Aug 6, 2018 |
| Countries | Argentina, Australia, Austria, Belgium, Bulgaria, Canada, Chile, Colombia, Croatia, Czechia, Denmark, Germany and 21 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: